Deep brain stimulation and the ethics of protection and caring for the patient with Parkinson's dementia

S Farris, P Ford, J DeMarco… - … disorders: official journal …, 2008 - Wiley Online Library
Deep brain stimulation (DBS) is an effective neurosurgical treatment for patients with
advanced Parkinson's disease (PD) suffering from motor complications that are refractory to …

Ethical issues surrounding deep brain stimulation in Parkinson's disease

SM Farris, FJ Gianola - JAAPA, 2009 - journals.lww.com
Deep brain stimulation (DBS) is an elective neurosurgical treatment for patients with
advanced Parkinson's disease (PD) who suffer from symptoms refractory to medication. DBS …

Clinical ethics in the context of deep brain stimulation for movement disorders

CS Kubu, PJ Ford - Archives of Clinical Neuropsychology, 2017 - academic.oup.com
Objective Discuss common clinical ethical challenges encountered in working with patients
who are candidates for deep brain stimulation (DBS) for the treatment of motor symptoms of …

Ethical issues in deep brain stimulation

PR Wolpe, PJ Ford, M Harhay - Neurological Disease and …, 2007 - books.google.com
Deep brain stimulation (DBS) is a fairly recent surgical therapy for the treatment of
Parkinson's disease (PD), having first won Food and Drug Administration (FDA) approval in …

[HTML][HTML] Once STN DBS, always STN DBS?—clinical, ethical, and financial reflections on deep brain stimulation for parkinson's disease

M Hariz - Movement Disorders Clinical Practice, 2016 - ncbi.nlm.nih.gov
At the 11th Parkinson's Disease symposium in Rome in March 1994, where neurologist
Pierre Pollak presented, for the first time, the results of DBS of the STN, the late Professor …

Incoming ethical issues for deep brain stimulation: When long-term treatment leads to a 'new form of the disease'

F Gilbert, M Lancelot - Journal of Medical Ethics, 2021 - jme.bmj.com
Deep brain stimulation (DBS) has been regarded as an efficient and safe treatment for
Parkinson's disease (PD) since being approved by the Food and Drug Administration (FDA) …

Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting

A Videnovic, LV Metman - Movement disorders: official journal …, 2008 - Wiley Online Library
Deep brain stimulation (DBS) has assumed a prominent role in the treatment of Parkinson's
disease (PD). In this manuscript, we attempt to estimate the prevalence and categorize …

Multicenter study on deep brain stimulation in Parkinson's disease: an independent assessment of reported adverse events at 4 years

MI Hariz, S Rehncrona, NP Quinn… - … : official journal of the …, 2008 - Wiley Online Library
Ongoing adverse events (AEs) at 4‐years postsurgery in 69 patients with advanced
Parkinson′ s disease (PD) who received deep brain stimulation (DBS) of the subthalamic …

The ethics of expanding applications of deep brain stimulation

M Christen, S Müller - The Routledge Handbook of Neuroethics, 2017 - taylorfrancis.com
This chapter discusses the intervention as such, exemplified by its most common indication,
Parkinson's disease (PD). It outlines the challenges of patients who may be candidates for …

Patients with cognitive impairment in Parkinson's disease benefit from deep brain stimulation: a case‐control study

CK Block, M Patel, BB Risk, E Staikova… - Movement Disorders …, 2023 - Wiley Online Library
Background Deep brain stimulation (DBS) for Parkinson's disease (PD) is generally
contraindicated in persons with dementia but it is frequently performed in people with mild …